Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Novel Drug Targets for the Bradyzoite Form of Toxoplasma gondii

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Ortiz,Justin; Potter,Anna; Benmerzouga,Imaan
  • Document Type:
    Electronic Resource
  • Online Access:
    https://www.dovepress.com/novel-drug-targets-for-the-bradyzoite-form-of-toxoplasma-gondii-peer-reviewed-fulltext-article-RRTM
    info:eu-repo/semantics/altIdentifier/doi/10.2147/RRTM.S431290
  • Additional Information
    • Publisher Information:
      Dove Press 2025-03-29
    • Abstract:
      Justin Orlando Ortiz, Anna K Potter, Imaan Benmerzouga Kiran C. Patel College of Osteopathic Medicine, Department of Foundational Sciences, Clearwater, FL, USACorrespondence: Imaan Benmerzouga, Email ibenmerz@nova.eduAbstract: Toxoplasma gondii is a world-wide parasite, with an estimated prevalence of approximately 30%. Toxoplasmosis is a severe disease in the immunocompromised, but few symptoms are exhibited by patients with an intact immune system, making this parasite a worldwide burden. Currently, few drugs exist in treating acute toxoplasmosis and no drugs exist to eliminate the bradyzoite of T. gondii. Effective therapies against acute and chronic toxoplasmosis are urgently needed to reduce the burden of this disease. This review aims to give a summary of recent findings in the bradyzoite form of Toxoplasma gondii and the implication of these findings on drug development. A thorough search of PubMed and Google Scholar databases was used to identify studies within the past 10 years that illustrate targetable key elements in the differentiation and formation of the bradyzoite form of T. gondii.Keywords: chronic toxoplasmosis, bradyzoite, toxoplasmosis, anti-toxoplasma agents, Toxoplasma gondii
    • Subject Terms:
      Research and Reports in Tropical Medicine; Review; info:eu-repo/semantics/article
    • Availability:
      Open access content. Open access content
      info:eu-repo/semantics/openAccess
    • Note:
      text/html
      English
    • Other Numbers:
      NZDMP oai:dovepress.com/101592
      1519880765
    • Contributing Source:
      DOVE MEDL PRESS LTD
      From OAIster®, provided by the OCLC Cooperative.
    • Accession Number:
      edsoai.on1519880765
HoldingsOnline